Report cover image

Influenza Vaccines Market, by Vaccine Type (Trivalent Vaccines and Quadrivalent Vaccines), by Virus Type (Influenza Virus A and Influenza Virus B), by Age Group (Pediatrics and Adults), and by Region (North America, Latin America, Europe, Asia Pacific,

Publisher Coherent Market Insights
Published Jun 20, 2022
Length 197 Pages
SKU # CMI17292101

Description

Influenza Vaccines Market, by Vaccine Type (Trivalent Vaccines and Quadrivalent Vaccines), by Virus Type (Influenza Virus A and Influenza Virus B), by Age Group (Pediatrics and Adults), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Influenza is an infection caused by influenza virus and is commonly known as flu. Vaccination for influenza aids in prevention of flu. This vaccine is recommended for children aged 6 months and older. Moreover, according to the World Health Organization (WHO), influenza virus is transmitted primarily by respiratory secretions or droplets of the infected person. It has an annual global attack rate of 5-10% in adults and 20–30% in children. Influenza vaccines are available with a wide range of options for different age groups such as children aged 6 months and above and adults aged 65 and above. According to the Centers for Disease Control and Prevention (CDC), 2021, in the U.S., 1,675 (0.2%) of 818,939 respiratory specimens were tested positive for an influenza virus. There are various type of vaccine type such as the trivalent vaccine (TIV) which contains one influenza B antigens and The Quadrivalent influenza vaccine (QIV) contains two influenza B antigens.

Market Dynamics

Investments by the key players in influenza vaccines market, in order to develop new innovative technologies and to increase production capacity is expected to drive the market growth. For instance, in December 2019, the U.S. Department of Health and Human Services (HHS) announced that it has invested US$ 226 million, a six-year contract, to increase the capacity to produce recombinant influenza vaccine in the U.S. The manufacturing of vaccines will be initiated through a public-private partnership between the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), and Sanofi Pasteur which is pharmaceutical company.

Key features of the study:
  • This report provides an in-depth analysis of the global influenza vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global influenza vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include Seqirus, GlaxoSmithKline plc, Sanofi, AstraZeneca, FluGen, Inc., Moderna, Inc., Biocryst Pharmaceuticals, Inc., CPL Biologicals Pvt. Ltd., CureVac AG, OSIVAX, and Solaris Vaccines
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global influenza vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global influenza vaccines market
Detailed Segmentation:
  • Global Influenza Vaccines Market, by Vaccine Type:
  • Trivalent Vaccines
  • Quadrivalent Vaccines
  • Global Influenza Vaccines Market, by Virus Type:
  • Influenza Virus A
  • Influenza Virus B
  • Global Influenza Vaccines Market, by Age Group:
  • Pediatrics
  • Adults
  • Global Influenza Vaccines Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Seqirus *
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • GlaxoSmithKline plc,
  • Sanofi,
  • AstraZeneca,
  • FluGen, Inc.,
  • Moderna, Inc.,
  • Biocryst Pharmaceuticals, Inc.,
  • CPL Biologicals Pvt. Ltd.,
  • CureVac AG,
  • OSIVAX
  • Solaris Vaccines
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

197 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Vaccine Type
Market Snapshot, By Virus Type
Market Snapshot, By Age Group
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunity
Impact Analysis
Key Developments
Industry Trends
Regulatory Scenario
Recent Product Approval/Launches
PEST Analysis
Porter’s Analysis
4. Global Influenza Vaccines Market– Impact of Coronavirus (COVID-19) Pandemic
Impact on Demand
Impact on Healthcare
Epidemiology
5. Global Influenza Vaccines Market, By Vaccine Type, 2017 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Trivalent Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Quadrivalent Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
6. Global Influenza Vaccines Market, By Virus Type, 2017 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Influenza Virus Type A
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Influenza Virus Type B
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
7. Global Influenza Vaccines Market, By Age Group, 2017 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Pediatrics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
8. Global Influenza Vaccines Market, By Region, 2017 – 2030 (US$ Million)
Introduction
Market Share Analysis, By Region, 2022 and 2030(%)
Y-o-Y Growth Analysis, For Regions, 2018 - 2030
Regional Trends
North America
Market Size and Forecast, By Vaccine Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Virus Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Age Group, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Vaccine Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Virus Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Age Group, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Vaccine Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Virus Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Age Group, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Vaccine Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Virus Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Age Group, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Vaccine Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Virus Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Age Group, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030 (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Vaccine Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Virus Type, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Age Group, 2017 – 2030 (US$ Mn)
Market Size and Forecast, By Region/Country, 2017 – 2030 (US$ Mn)
South Africa
Central Africa
North Africa
9. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Seqirus
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AstraZeneca
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
FluGen, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Moderna, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
CPL Biologicals Pvt. Ltd.,
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
CureVac AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
OSIVAX
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Solaris Vaccines
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
10. Section
Research Methodology
About Us
*Browse 40 market data tables and 48 figures on “Global Influenza Vaccines Market” - forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us